APRT Human

Adenine Phosphoribosyltransferase Human Recombinant
Shipped with Ice Packs
In Stock

Description

Biochemical Function and Pathway Role

APRT catalyzes the conversion of adenine and phosphoribosyl pyrophosphate (PRPP) into adenosine monophosphate (AMP) and pyrophosphate (PPi), a key reaction in the purine salvage pathway . This pathway enables energy-efficient recycling of adenine from dietary sources or cellular degradation, bypassing de novo nucleotide synthesis.

Key Reaction:

Adenine + PRPPAPRTAMP + PPi\text{Adenine + PRPP} \xrightarrow{\text{APRT}} \text{AMP + PPi}
  • Physiological Importance:

    • Essential during rapid growth phases (e.g., embryogenesis, tumor proliferation) .

    • Sole pathway for AMP synthesis in protozoan parasites (e.g., Trypanosoma brucei), making APRT a potential drug target .

    • Processes cytokinins in plants, linking purine metabolism to hormonal regulation .

Genetic Basis and Mutations

The APRT gene (chromosome 16q24) spans <2.6 kb with five exons . Over 40 mutations are linked to APRT deficiency, categorized into two types:

Deficiency TypeMutation CharacteristicsPopulation PrevalenceClinical Impact
Type I (APRT*Q0)Frameshifts, nonsense mutations (e.g., IVS4+2insT)Predominantly EuropeanComplete loss of enzyme activity
Type II (APRT*J)Missense mutations (e.g., M136T)Primarily JapaneseReduced PRPP affinity (↑ KMK_M)
  • Consequences:

    • Accumulation of adenine → conversion to insoluble 2,8-dihydroxyadenine (DHA) via xanthine dehydrogenase .

    • DHA crystallizes in kidneys, causing urolithiasis and nephropathy .

Clinical Implications and Management

APRT deficiency (OMIM 102600) manifests as recurrent kidney stones or chronic kidney disease :

Diagnostic MethodKey Findings
Urine microscopyDHA crystals (spherical, brown, radial striations)
Stone analysis (FTIRM)Radiolucent DHA stones
Erythrocyte APRT assay<10% residual activity in Type I deficiency

Treatment Strategies:

  • Pharmacological: Allopurinol/febuxostat (xanthine dehydrogenase inhibitors) reduce DHA production .

  • Dietary: Low-purine diet and high fluid intake .

Evolutionary and Comparative Insights

APRT is highly conserved across species, with 82% sequence identity between human and mouse enzymes . Structural motifs, such as the PRPP-binding region and flexible loop, are preserved, underscoring functional constraints . Protozoan APRT homologs (e.g., Trypanosoma brucei APRT1) are kinetically active, unlike misannotated paralogs (APRT2) , highlighting the enzyme’s evolutionary divergence.

Research Advancements

Recent studies using X-ray crystallography and QM/MM simulations revealed:

  • Substrate Specificity: APRT binds adenine via shape complementarity in the forward reaction but exhibits base specificity in the reverse direction .

  • Catalytic Mechanism: Forward reaction proceeds via an SN_N2 nucleophilic substitution, with pyrophosphate release as the rate-limiting step .

Therapeutic Potential:

  • Targeting APRT in parasites (e.g., Giardia) could disrupt purine salvage, offering antiparasitic strategies .

Product Specs

Introduction
Adenine phosphoribosyltransferase (APRT) is an enzyme involved in the purine salvage pathway. It catalyzes the conversion of adenine to AMP, utilizing 5-phosphoribosyl-1-pyrophosphate (PRPP) as a co-substrate. This reaction is crucial for maintaining adenine nucleotide pools. Deficiencies in APRT can lead to the accumulation of adenine, resulting in the formation of kidney stones composed of 2,8-dihydroxyadenine.
Description
Recombinant human APRT, expressed in E. coli, is available as a purified, non-glycosylated protein. It consists of a single polypeptide chain comprising 180 amino acids, corresponding to the full-length protein sequence (amino acids 1-180). The molecular weight of the protein is 19.6 kDa. Purification is achieved through standard chromatographic techniques.
Physical Appearance
Clear, colorless solution, sterile-filtered.
Formulation
The protein is supplied in a buffer consisting of 20 mM Tris-HCl (pH 8.0), 1 mM dithiothreitol (DTT), and 10% glycerol.
Stability
For short-term storage (up to 4 weeks), the product can be stored at 4°C. For extended storage, it is recommended to freeze the product at -20°C. To ensure long-term stability during frozen storage, the addition of a carrier protein such as albumin (0.1% HSA or BSA) is advised. Repeated freezing and thawing should be avoided.
Purity
The purity of the protein is greater than 90%, as determined by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) analysis.
Synonyms
EC 2.4.2.73, MGC125857, AMP diphosphorylase, Adenine phosphoribosyltransferase, APRT, AMP, MGC125856, MGC129961, DKFZp686D13177.
Source
Escherichia Coli.
Amino Acid Sequence
MADSELQLVE QRIRSFPDFP TPGVVFRDIS PVLKDPASFR AAIGLLARHL KATHGGRIDY IAGLDSRGFL FGPSLAQELG LGCVLIRKRG KLPGPTLWAS YSLEYGKAEL EIQKDALEPG QRVVVVDDLL ATGGTMNAAC ELLGRLQAEV LECVSLVELT SLKGREKLAP VPFFSLLQYE.

Q&A

What is the structural organization of the human APRT gene?

The functional human APRT gene is remarkably compact, spanning less than 2.6 kilobases in length and containing five exons. Unlike many other genes, its promoter region lacks conventional "TATA" and "CCAAT" boxes but features five GC boxes that serve as potential binding sites for the Sp1 transcription factor .

Research methodologies for studying APRT gene structure include:

  • Genomic DNA sequencing

  • Comparative sequence analysis between species

  • Restriction mapping

  • Promoter deletion analysis

Interestingly, comparative analysis between human and mouse APRT genes reveals high homology within protein-coding regions but minimal significant homology in 5' flanking, 3' untranslated, and intronic sequences. A notable exception is a 26-base-pair region in intron 3 that shows 92% sequence identity between human and mouse, suggesting strong selective pressure for its maintenance .

How has APRT enzyme structure been conserved throughout evolution?

The APRT enzyme demonstrates remarkable evolutionary conservation, reflecting its fundamental metabolic importance across species. Amino acid sequence comparisons reveal that human APRT shares significant homology with other organisms:

SpeciesPercent Identity to Human APRT
Hamster90%
Mouse82%
E. coli40%

This high degree of conservation, particularly among mammals, indicates strong selective pressure against structural changes in the protein . Additionally, the positions of all introns have been precisely retained between human and rodent APRT genes, as has an unusual AG/GC donor splice site in intron 2, further demonstrating evolutionary constraints on gene architecture .

Methodological approaches to studying evolutionary conservation include:

  • Multiple sequence alignment

  • Phylogenetic analysis

  • Structure-function relationship studies

  • Site-directed mutagenesis of conserved residues

What laboratory techniques are most effective for identifying APRT mutations?

Researchers employ multiple complementary techniques to identify and characterize APRT mutations:

  • Nucleotide sequence analysis: Direct sequencing of patient genomic DNA to identify specific nucleotide changes, as demonstrated in the characterization of the Japanese-type mutation .

  • RNase mapping analysis: Detection of mismatches between wild-type and mutant RNA sequences to confirm mutations across multiple patient samples .

  • PCR with allele-specific oligonucleotide (ASO) probes: After amplifying regions containing mutations of interest, dot-blot analysis with normal and mutated ASO probes can distinguish between normal individuals, heterozygous carriers, and homozygous affected individuals .

  • Restriction enzyme digestion: For mutations that create or abolish restriction sites, this approach provides a simple screening method .

  • APRT enzyme activity assays: Measuring enzyme activity in red blood cell lysates to identify functional deficiencies that may guide genetic analysis.

The integration of these methodologies has enabled comprehensive identification of mutations such as the Japanese-type mutation, a T to C substitution in exon 5 resulting in methionine to threonine replacement at position 136 .

What are the pathophysiological consequences of APRT deficiency?

APRT deficiency (APRTD) is an autosomal recessive disorder with an estimated prevalence of 1:50,000-1:100,000 . The primary clinical manifestation is 2,8-DHA urolithiasis, resulting from the metabolic diversion of adenine to 2,8-DHA.

The pathophysiological sequence includes:

  • Deficient APRT enzyme activity

  • Metabolism of adenine to 2,8-DHA by xanthine dehydrogenase

  • Excretion and precipitation of insoluble 2,8-DHA in urine

  • Formation of crystals and stones in the urinary tract

  • Potential development of crystalline nephropathy and kidney damage

Clinical presentation varies widely, with many affected individuals remaining asymptomatic until adulthood . Effective prevention strategies include XDH inhibitors (allopurinol or febuxostat), dietary purine restriction, and increased fluid intake, which can not only prevent complications but also help dissolve existing stones and improve kidney function in patients with renal failure .

How does the unusual CpG dinucleotide arrangement in the APRT gene influence its regulation?

The APRT gene exhibits a striking and non-random distribution of CpG dinucleotides. Although intron 1 and 5' flanking regions of human and mouse APRT genes lack substantial sequence homology, both maintain a significantly higher frequency of CpG dinucleotides than would be expected based on random distribution .

This phenomenon suggests evolutionary selection for maintaining specific CpG patterns despite sequence divergence, implying functional importance. Methodological approaches to investigate this include:

  • Computational analysis of CpG distribution and methylation patterns

  • Reporter gene assays with constructs containing various CpG-rich regions

  • Targeted methylation studies to assess impact on gene expression

  • Chromatin immunoprecipitation to identify proteins interacting with these regions

The retention of this unusual CpG arrangement may be critical for proper APRT gene function, potentially through:

  • Formation of regulatory CpG islands affecting transcription

  • Influence on chromatin structure and accessibility

  • Interaction with methyl-CpG binding proteins

  • Effects on RNA processing or stability

What kinetic abnormalities characterize mutant APRT enzymes, and how are they best measured?

The Japanese-type mutation and other APRT variants exhibit distinctive kinetic abnormalities that can be characterized through several methodological approaches:

  • Enzyme activity assays: Quantifying the rate of AMP formation using radioisotope-labeled substrates to measure specific activity.

  • Substrate affinity determination: Calculating Michaelis constants (Km) for adenine and PRPP by measuring reaction rates across substrate concentration ranges to detect altered binding affinity.

  • Thermal stability profiling: Assessing enzyme activity after incubation at various temperatures to evaluate structural stability.

  • Heterologous expression systems: Producing recombinant wild-type and mutant proteins for direct biochemical comparison.

Research on Japanese-type APRT deficiency revealed "strikingly similar abnormalities" in affected individuals, suggesting a distinct phenotype associated with the Met136→Thr substitution . This consistent pattern of altered enzyme kinetics provides a biochemical signature that correlates with the genetic mutation, offering mechanistic insights into the molecular pathophysiology of APRT deficiency.

What mechanisms explain the conservation of specific intronic sequences in the APRT gene across species?

The identification of a highly conserved 26-base-pair sequence in intron 3 that shows 92% identity between human and mouse APRT genes raises intriguing questions about intronic function . This sequence is also present in the hamster gene, suggesting strong evolutionary constraints.

Methodological approaches to investigate this phenomenon include:

  • RNA secondary structure prediction: Computational analysis to identify potential structural elements formed by the conserved sequence.

  • Splice regulatory element analysis: Investigating whether the conserved sequence influences exon recognition or splicing efficiency.

  • CRISPR-mediated deletion: Targeted removal of the conserved sequence to assess functional consequences.

  • RNA-protein interaction studies: Identifying potential trans-acting factors that might bind this element.

  • Comparative genomics: Extending the analysis to additional species to determine the evolutionary depth of conservation.

The precise retention of all intron positions between human and rodent APRT genes, along with the unusual AG/GC donor splice site in intron 2, further suggests that specific intronic features play functional roles beyond being mere spacers between exons .

How can population genetics approaches enhance our understanding of APRT mutations?

The Japanese-type mutation (Met136→Thr) provides an excellent model for studying population-specific genetic variants. All seven Japanese-type homozygotes studied carried the same mutation on both alleles, indicating a founder effect in this population .

Methodological approaches for population genetics studies of APRT include:

  • Haplotype analysis: Southern blot analysis showed that all seven Japanese-type subjects were confined to one TaqI restriction fragment length polymorphism (RFLP) haplotype .

  • Allele-specific PCR screening: Development of rapid screening methods using ASO probes has enabled efficient identification of carriers in population studies .

  • Geographic distribution mapping: Analyzing the prevalence of specific mutations across different regions to trace migration patterns and founder effects.

  • Age estimation of mutations: Using genetic diversity around the mutation site to estimate when the mutation first appeared in the population.

These approaches not only enhance our understanding of APRT deficiency epidemiology but also provide insights into human population history and migration patterns. The high frequency of the Japanese-type mutation in a specific population makes it a valuable model for studying inheritance patterns of recessive disorders.

What experimental approaches can elucidate the transcriptional regulation of the APRT gene?

The distinctive promoter architecture of the APRT gene—lacking conventional TATA and CCAAT boxes but containing GC-rich regions—presents an interesting model for studying transcriptional regulation of housekeeping genes. Effective methodological approaches include:

  • Promoter deletion analysis: Creating a series of constructs with progressive deletions to identify essential regulatory elements. This approach revealed that the distal three GC boxes are dispensable for gene expression .

  • Site-directed mutagenesis: Targeted modification of specific GC boxes to assess their individual contributions to promoter activity.

  • Chromatin immunoprecipitation (ChIP): Verification of in vivo binding of Sp1 and other transcription factors to the APRT promoter.

  • DNase I hypersensitivity assays: Identification of open chromatin regions that may function as regulatory elements.

  • CRISPR interference/activation: Targeted modulation of promoter activity to identify critical regulatory regions.

The unusual CpG dinucleotide arrangement in the APRT gene further complicates transcriptional regulation, as CpG methylation status may influence promoter activity . Integrated analysis of both genetic and epigenetic factors is therefore essential for a comprehensive understanding of APRT gene regulation.

Product Science Overview

Introduction

Adenine Phosphoribosyltransferase (APRT) is an enzyme encoded by the APRT gene, located on chromosome 16 in humans . This enzyme plays a crucial role in the purine salvage pathway, which is essential for recycling purines to synthesize nucleotides efficiently .

Structure and Function

APRT belongs to the Type I Phosphoribosyltransferase (PRTase) family . The enzyme catalyzes the transfer of a phosphoribosyl group from phosphoribosyl pyrophosphate (PRPP) to adenine, forming adenosine monophosphate (AMP) and pyrophosphate (PPi) . The reaction can be summarized as follows:

Adenine+PRPPAMP+PPi\text{Adenine} + \text{PRPP} \rightarrow \text{AMP} + \text{PPi}

This reaction is vital for the nucleotide salvage pathway, providing an alternative to the energetically expensive de novo synthesis of nucleotides .

Biological Significance

APRT is present in all tissues and is the only known mechanism for the metabolic salvage of adenine derived from polyamine biosynthesis or dietary sources . In parasitic protozoa, such as Giardia, APRT provides the sole mechanism for AMP production .

Clinical Relevance

APRT deficiency can lead to serious kidney conditions, including nephrolithiasis (kidney stones), interstitial nephritis, and chronic renal failure . This is due to the precipitation of 2,8-dihydroxyadenine (DHA) crystals in the renal interstitium . Understanding the structure and function of APRT is crucial for developing treatments for these conditions.

Recombinant APRT

Human recombinant APRT is produced using Escherichia coli as an expression system . The recombinant enzyme has been crystallized and studied using X-ray diffraction, revealing a structure composed of nine beta-strands and six alpha-helices . The active site pocket of APRT opens slightly to accommodate the AMP product, and structural comparisons with other PRTases have provided insights into the enzyme’s specificity and function .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.